// App-Quantinova.ai

: ISCHEMIC AND BLEEDING OUTCOMES OF CARRIERS OF CYP2C19*17 TREATED WITH CLOPIDOGREL: INSIGHTS FROM THE TAILOR-PCI STUDY

Researchers

Presenter

  • Derek Yiu Fai So

Principal Investigators

  • Linnea Baudhuin

  • Michael Farkouh

  • Shaun Goodman

  • Verghese Mathew

  • Vishakantha Murthy

  • Louai Razzouk

  • Ganesh Raveendran

  • Kirk Garratt

  • Alan Wu

  • Mina Madan

  • Ryan Lennon

  • Naveen Pereira

Medical Centers

  • Mayo Clinic, Rochester, MN

  • University of Ottawa Heart Institute, Ottawa, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved